ENALAPRILAT (Hospira, Inc.)
Welcome to the PulseAid listing for the ENALAPRILAT drug offered from Hospira, Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | ENALAPRILAT |
| SUBSTANCE NAME: | ENALAPRILAT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2005-08-24 |
| END MARKETING DATE: | 0000-00-00 |
ENALAPRILAT HUMAN PRESCRIPTION DRUG Details:
| Item Description | ENALAPRILAT from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.25(mg/mL) |
| START MARKETING DATE: | 2005-08-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0409-2122_e6dc115e-1410-428b-8b85-e96d191f2f71 |
| PRODUCT NDC: | 0409-2122 |
| APPLICATION NUMBER: | ANDA075458 |
Other ENALAPRILAT Pharmaceutical Manufacturers / Labelers:
